Fifth Third Bancorp
NXTM

Fifth Third Bancorp’s NxStage Medical Inc. NXTM Stock Holding History

Fifth Third Bancorp’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-522
Closed -$7K – 2275
2013
Q3 		$7K Buy
+522
New +$6.85K ﹤0.01% 1975

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return

Fifth Third Bancorp's NXTM Position: Q4 2013 in Review

Fifth Third Bancorp sold out of NxStage Medical Inc. (NXTM) in Q4 2013, closing a stake of 522 shares — an estimated $7K sold.

Fifth Third Bancorp first reported a position in NXTM in Q3 2013 and held it in 1 quarter. The position peaked at $7K in Q3 2013. 114 funds tracked by Wall St. Rank hold NXTM as of Q4 2013.

  • Fifth Third Bancorp reported no remaining NxStage Medical Inc. position as of Q4 2013 after selling out during the quarter.
  • Fifth Third Bancorp sold 522 NxStage Medical Inc. shares in Q4 2013, an estimated $7K.
  • Fifth Third Bancorp first reported a position in NxStage Medical Inc. in Q3 2013 and held it in 1 quarter.
  • Fifth Third Bancorp's NxStage Medical Inc. position peaked at $7K in Q3 2013.
  • 114 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2013.

Based on Fifth Third Bancorp's 13F filing for Q4 2013, filed 14 Feb 2014.